AllianceBernstein
DTIL icon

AllianceBernstein’s Precision BioSciences DTIL Stock Holding History

AllianceBernstein’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,327
Closed -$123K – 3295
2022
Q1 		$123K Sell
1,327
-246
-16% -$33.4K ﹤0.01% 3093
2021
Q4 		$349K Hold
1,573
– – ﹤0.01% 2897
2021
Q3 		$545K Hold
1,573
– – ﹤0.01% 2721
2021
Q2 		$591K Buy
1,573
+226
+17% +$67.9K ﹤0.01% 2749
2021
Q1 		$418K Sell
1,347
-780
-37% -$273K ﹤0.01% 2747
2020
Q4 		$532K Hold
2,127
– – ﹤0.01% 2558
2020
Q3 		$393K Sell
2,127
-44
-2% -$8.75K ﹤0.01% 2659
2020
Q2 		$543K Buy
2,171
+833
+62% +$182K ﹤0.01% 2559
2020
Q1 		$242K Sell
1,338
-49,601
-97% -$13M ﹤0.01% 2717
2019
Q4 		$21.2M Buy
50,939
+50,422
+9,753% +$15.8M 0.01% 803
2019
Q3 		$130K Buy
+517
New +$168K ﹤0.01% 3036
2019
Q2 		– Sell
-4,037
Closed -$2.17M – 3157
2019
Q1 		$2.17M Buy
+4,037
New +$2.14M ﹤0.01% 1842

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AllianceBernstein's DTIL Position: Q2 2022 in Review

AllianceBernstein sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 1,327 shares — an estimated $123K sold.

AllianceBernstein first reported a position in DTIL in Q1 2019 and held it in 12 quarters. The position peaked at $21.2M in Q4 2019. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • AllianceBernstein reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 1,327 Precision BioSciences shares in Q2 2022, an estimated $123K.
  • AllianceBernstein first reported a position in Precision BioSciences in Q1 2019 and held it in 12 quarters.
  • AllianceBernstein's Precision BioSciences position peaked at $21.2M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.